The impact of aryl hydrocarbon receptor signaling on matrix metabolism: Implications for development and disease

Biological Chemistry

Volumn 387, Issue 9, 2006, Pages 1159-1173

  Hillegass, Jedd M ^a   Murphy, Kyle A ^a   Villano, Caren M ^a   White, Lori A ^a  

^a RUTGERS UNIVERSITY   (United States)

Author keywords

2,3,7,8 tetrachlorodibenzo p dioxin (TCDD); AhR; Development; ECM; Extracellular matrix; Matrix metalloproteinase; MMP

Indexed keywords

2,3,7,8 TETRACHLORODIBENZO PARA DIOXIN; 3 METHYLCHOLANTHRENE; AROMATIC HYDROCARBON RECEPTOR; COLLAGENASE; GELATINASE; GLYCOPROTEIN; MATRILYSIN; MATRIX METALLOPROTEINASE; POLYCYCLIC AROMATIC HYDROCARBON; PROTEOGLYCAN; STROMELYSIN;

ANGIOGENESIS; CONGENITAL MALFORMATION; DEVELOPMENTAL DISORDER; ENZYME ACTIVITY; ENZYME STRUCTURE; EXTRACELLULAR MATRIX; GENE EXPRESSION; HUMAN; MELANOMA; MOLECULAR MECHANICS; NONHUMAN; NUCLEOTIDE SEQUENCE; PATHOGENESIS; PRENATAL EXPOSURE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SYNTHESIS; REVIEW; RNA TRANSLATION; TISSUE REGENERATION; TRANSCRIPTION INITIATION; UNINDEXED SEQUENCE;

ANIMALS; DISEASE; HUMANS; MATRIX METALLOPROTEINASES; NF-KAPPA B; RECEPTORS, ARYL HYDROCARBON; SIGNAL TRANSDUCTION; TETRACHLORODIBENZODIOXIN; TRETINOIN;

EID: 33748740824     PISSN: 14316730     EISSN: 14374315     Source Type: Journal    
DOI: 10.1515/BC.2006.144     Document Type: Review

References (137)

1. Abbott, B.D. and Birnbaum, L.S. (1989). TCDD alters medial epithelial cell differentiation during palatogenesis. Toxicol. Appl. Pharmacol. 99, 276-286.
2. Andreasen, E.A., Mathew, L.K., and Tanguay, R.L. (2006). Regenerative growth is impacted by TCDD: gene expression analysis reveals extracellular matrix modulation. Toxicol. Sci. 92, 254-269.
3. Antkiewicz, D.S., Burns, C.G., Carney, S.A., Peterson, R.E., and Heideman, W. (2005). Heart malformation is an early response to TCDD in embryonic zebrafish. Toxicol. Sci. 84, 368-377.
4. Ardelt, A.A., McCullough, L.D., Korach, K.S., Wang, M.M., Munzenmaier, D.H., and Hurn, P.D. (2005). Estradiol regulates angiopoietin-1 mRNA expression through estrogen receptor-α in a rodent experimental stroke model. Stroke 36, 337-341.
5. Bai, S., Thummel, R., Godwin, A.R., Nagase, H., Itoh, Y., Li, L., Evans, R., McDermott, J., Seiki, M., and Sarras, M.P. Jr. (2005). Matrix metalloproteinase expression and function during fin regeneration in zebrafish: analysis of MT1-MMP, MMP2 and TIMP2. Matrix Biol. 24, 247-260.
6. Barchowsky, A., Frleta, D., and Vincenti, M.P. (2000). Integration of the NF-κB and mitogen-activated protein kinase/AP-1 pathways at the collagenase-1 promoter: divergence of IL-1 and TNF-dependent signal transduction in rabbit primary synovial fibroblasts. Cytokine 12, 1469-1479.
7. Baruah, D.B., Dash, R.N., Chaudhari, M.R., and Kadam, S.S. (2006). Plasminogen activators: a comparison. Vasc. Pharmacol. 44, 1-9.
8. Beischlag, T.V. and Perdew, G.H. (2005). ER alpha-AHR-ARNT protein-protein interactions mediate estradiol-dependent transrepression of dioxin-inducible gene transcription. J. Biol. Chem. 280, 21607-21611.
9. Bello, S.M., Heideman, W., and Peterson, R.E. (2004). 2,3,7,8-Tetrachlorodibenzo-p-dioxin inhibits regression of the common cardinal vein in developing zebrafish. Toxicol. Sci. 78, 258-266.
10. Benbow, U. and Brinckerhoff, C.E. (1997). The AP-1 site and MMP gene regulation: what is all the fuss about? Matrix Biol. 15, 519-526.
11. Benbow, U., Rutter, J.L., Lowrey, C.H., and Brinckerhoff, C.E. (1999). Transcriptional repression of the human collagenase-1 (MMP-1) gene in MDA231 breast cancer cells by all-transretinoic acid requires distal regions of the promoter. Br. J. Cancer 79, 221-228.
12. Benedict, J.C., Lin, T.M., Loeffler, I.K., Peterson, R.E., and Flaws, J.A. (2000). Physiological role of the aryl hydrocarbon receptor in mouse ovary development. Toxicol. Sci. 56, 382-388.
13. Bertazzi, P.A., Bernucci, I., Brambilla, G., Consonni, D., and Pesatori, A.C. (1998). The Seveso studies on early and long-term effects of dioxin exposure: a review. Environ. Health Perspect. 106 (Suppl. 2), 625-633.
14. Bertazzi, P.A., Consonni, D., Bachetti, S., Rubagotti, M., Baccarelli, A., Zocchetti, C., and Pesatori, A.C. (2001). Health effects of dioxin exposure: a 20-year mortality study. Am. J. Epidemiol. 153, 1031-1044.
15. Bigg, H.F., McLeod, R., Waters, J.G., Cawston, T.E., and Clark, I.M. (2000). Mechanisms of induction of human tissue inhibitor of metalloproteinases-1 (TIMP-1) gene expression by all-trans retinoic acid in combination with basic fibroblast growth factor. Eur. J. Biochem. 267, 4150-4156.
16. Bocchinfuso, W.P. and Korach, K.S. (1997). Mammary gland development and tumorigenesis in estrogen receptor knockout mice. J. Mammary Gland Biol. Neoplasia 2, 323-334.
17. Bock, K.W. and Kohle, C. (2006). Ah receptor: dioxin-mediated toxic responses as hints to deregulated physiologic functions. Biochem. Pharmacol. 72, 393-404.
18. Bode, W., Fernandez-Catalan, C., Tschesche, H., Grams, F., Nagase, H., and Maskos, K. (1999). Structural properties of matrix metalloproteinases. Cell Mol. Life Sci. 55, 639-652.
19. Brinckerhoff, C.E. and Matrisian, L.M. (2002). Matrix metalloproteinases: a tail of a frog that became a prince. Nat. Rev. Mol. Cell Biol. 3, 207-214.
20. Brouchet, L., Krust, A., Dupont, S., Chambon, P., Bayard, F., and Arnal, J.F. (2001). Estradiol accelerates reendothelializationin mouse carotid artery through estrogen receptor-α but not estrogen receptor-β. Circulation 103, 423-428.
21. Brown, N.M. and Lamartiniere, C.A. (1995). Xenoestrogens alter mammary gland differentiation and cell proliferation in the rat. Environ. Health Perspect. 103, 708-713.
22. Carver, L.A., LaPres, J.J., Jain, S., Dunham, E.E., and Bradfield, C.A. (1998). Characterization of the Ah receptor-associated protein, ARA9. J. Biol. Chem. 273, 33580-33587.
23. Chakraborti, S., Mandal, M., Das, S., Mandal, A., and Chakraborti, T. (2003). Regulation of matrix metalloproteinases: an overview. Mol. Cell Biochem. 253, 269-285.
24. Chambon, P. (1996). A decade of molecular biology of retinoic acid receptors. FASEB J. 10, 940-954.
25. Chandrasekar, B., Mummidi, S., Mahimainathan, L., Patel, D.N., Bailey, S.R., Imam, S.Z., Greene, W.C., and Valante, A.J. (2006). Interleukin-18-induced human coronary artery smooth muscle cell migration is dependent on NF-κB- and AP-1-mediated matrix metalloproteinase-9 expression, and is inhibited by atorvastatin. J. Biol. Chem. 281, 15099-15109.
26. Crews, S.T. and Fan, C.M. (1999). Remembrance of things PAS: regulation of development by bHLH-PAS proteins. Curr. Opin. Genet. Dev. 9, 580-587.
27. Dedieu, S. and Lefebvre, P. (2006). Retinoids interfere with the AP1 signalling pathway in human breast cancer cells. Cell. Signal. 18, 889-898.
28. Denison, M.S. and Nagy, S.R. (2003). Activation of the aryl hydrocarbon receptor by structurally diverse exogenous and endogenous chemicals. Annu. Rev. Pharmacol. Toxicol. 43, 309-334.
29. Deroo, B.J. and Korach, K.S. (2006). Estrogen receptors and human disease. J. Clin. Invest. 116, 561-570.
30. Dragnev, K.H., Rigas, J.R., and Dmitrovsky, E. (2000). The retinoids and cancer prevention mechanisms. Oncologist 5, 361-368.
31. Duan, R., Porter, W., Samudio, I., Vyhlidal, C., Kladde, M., and Safe, S. (1999). Transcriptional activation of c-fos protooncogene by 17β-estradiol: mechanism of aryl hydrocarbon receptor-mediated inhibition. Mol. Endocrinol. 13, 1511-1521.
32. Egeblad, M. and Werb, Z. (2002). New functions for the matrix metalloproteinases in cancer progression. Nat. Rev. Cancer 2, 161-174.
33. Fata, J.E., Leco, K.J., Moorehead, R.A., Martin, D.C., and Khokha, R. (1999). Timp-1 is important for epithelial proliferation and branching morphogenesis during mouse mammary development. Dev. Biol. 211, 238-254.
34. Flaws, J.A., Sommer, R.J., Silbergeld, E.K., Peterson, R.E., and Hirshfield, A.N. (1997). In utero and lactational exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) induces genital dysmorphogenesis in the female rat. Toxicol. Appl. Pharmacol. 147, 351-362.
35. Folgueras, A.R., Pendas, A.M., Sanchez, L.M., and Lopez-Otin, C. (2004). Matrix metalloproteinases in cancer: from new functions to improved inhibition strategies. Int. J. Dev. Biol. 48, 411-424.
36. Fujii-Kuriyama, Y., Imataka, H., Sogawa, K., Yasumoto, K., and Kikuchi, Y. (1992). Regulation of CYP1A1 expression. FASEB J. 6, 706-710.
37. Gaido, K.W., and Maness, S.C. (1995). Post-transcriptional stabilization of urokinase plasminogen activator mRNA by 2,3,7,8-tetrachlorodibenzo-p-dioxin in a human keratinocyte cell line. Toxicol. Appl. Pharmacol. 133, 34-42.
38. Ghosh, S., May, M.J., and Kopp, E.B. (1998). NF-κB and Rel proteins: evolutionarily conserved mediators of immune responses. Annu. Rev. Immunol. 16, 225-260.
39. Giannelli, G., Falk-Marzillier, J., Schiraldi, O., Stetler-Stevenson, W.G., and Quaranta, V. (1997). Induction of cell migration by matrix metalloprotease-2 cleavage of laminin-5. Science 277, 225-228.
40. Gillesby, B.E., Stanostefano, M., Porter, W., Safe, S., Wu, Z.F., and Zacharewski, T.R. (1997). Identification of a motif within the 5′ regulatory region of pS2 which is responsible for AP-1 binding and TCDD-mediated suppression. Biochemistry 36, 6080-6089.
41. Gonzalez, F.J., Fernandez-Salguero, P., Lee, S.S., Pineau, T., and Ward, J.M. (1995). Xenobiotic receptor knockout mice. Toxicol. Lett. 82-83, 117-121.
42. Gray, L.E. Jr. and Ostby, J.S. (1995). In utero 2,3,7,8- tetrachlorodibenzo-p-dioxin (TCDD) alters reproductive morphology and function in female rat offspring. Toxicol. Appl. Pharmacol. 133, 285-294.
43. Hamm, J.T., Sparrow, B.R., Wolf, D., and Birnbaum, L.S. (2000). In utero and lactational exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin alters postnatal development of seminal vesicle epithelium. Toxicol. Sci. 54, 424-430.
44. Han, Y.P., Tuan, T.L., Hughes, M., Wu, H., and Garner, W.L. (2001). Transforming growth factor-β- and tumor necrosis factor-α-mediated induction and proteolytic activation of MMP-9 in human skin. J. Biol. Chem. 276, 22341-22350.
45. Hankinson, O. (1995). The aryl hydrocarbon receptor complex. Annu. Rev. Pharmacol. Toxicol. 35, 307-340.
46. Hanlon, P.R., Cimafranca, M.A., Liu, X., Cho, Y.C., and Jefcoate, C.R. (2005). Microarray analysis of early adipogenesis in C3H10T1/2 cells: cooperative inhibitory effects of growth factors and 2,3,7,8-tetrachlorodibenzo- p-dioxin. Toxicol. Appl. Pharmacol. 207, 39-58.
47. Hendrix, M.J., Seftor, E.A., Kirschmann, D.A., Quaranta, V., and Seftor, R.E. (2003). Remodeling of the microenvironment by aggressive melanoma tumor cells. Ann. N.Y. Acad. Sci. 995, 151-161.
48. Henry, T.R., Spitsbergen, J.M., Hornung, M.W., Abnet, C.C., and Peterson, R.E. (1997). Early life stage toxicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin in zebrafish (Danio rerio). Toxicol. Appl. Pharmacol. 142, 56-68.
49. Hobson, L.B. (1984). Human effects of TCDD exposure. Bull. Environ. Contam. Toxicol. 33, 696-701.
50. Hockings, J.K., Thorne, P.A., Kemp, M.Q., Morgan, S.S., Selmin, O., and Romagnolo, D.F. (2006). The ligand status of the aromatic hydrocarbon receptor modulates transcriptional activation of BRCA-1 promoter by estrogen. Cancer Res. 66, 2224-2232.
51. Hoffer, A., Chang, C.Y., and Puga, A. (1996). Dioxin induces transcription of fos and jun genes by Ah receptor-dependent and -independent pathways. Toxicol. Appl. Pharmacol. 141, 238-247.
52. Hooiveld, M., Heederik, D.J., Kogevinas, M., Boffetta, P., Needham, L.L., Patterson, D.G. Jr., and Bueno-de-Mesquita, H.B. (1998). Second follow-up of a Dutch cohort occupationally exposed to phenoxy herbicides, chlorophenols, and contaminants. Am. J. Epidemiol. 147, 891-901.
53. Hushka, L.J., Williams, J.S., and Greenlee, W.F. (1998). Characterization of 2,3,7,8-tetrachlorodibenzofuran-dependent suppression and AH receptor pathway gene expression in the developing mouse mammary gland. Toxicol. Appl. Pharmacol. 152, 200-210.
54. Ivnitski, I., Elmaoued, R., and Walker, M.K. (2001). 2,3,7,8- Tetrachlorodibenzo-p-dioxin (TCDD) inhibition of coronary development is preceded by a decrease in myocyte proliferation and an increase in cardiac apoptosis. Teratology 64, 201-212.
55. Ivnitski-Steele, I.D., Friggens, M., Chavez, M., and Walker, M.K. (2005). 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) inhibition of coronary vasculogenesis is mediated, in part, by reduced responsiveness to endogenous angiogenic stimuli, including vascular endothelial growth factor A (VEGF-A). Birth Defects Res. A Clin. Mol. Teratol. 73, 440-446.
56. Ivnitski-Steele, I.D. and Walker, M.K. (2003). Vascular endothelial growth factor rescues 2,3,7,8-tetrachlorodibenzo-p-dioxin inhibition of coronary vasculogenesis. Birth Defects Res. A Clin. Mol. Teratol. 67, 496-503.
57. Jeon, M.S. and Esser, C. (2000). The murine IL-2 promoter contains distal regulatory elements responsive to the Ah receptor, a member of the evolutionarily conserved bHLH-PAS transcription factor family. J. Immunol. 165, 6975-6983.
58. Johansson, N., Ala-aho, R., Uitto, V., Grenman, R., Fusenig, N.E., Lopez-Otin, C., and Kahari, V.M. (2000). Expression of collagenase-3 (MMP-13) and collagenase-1 (MMP-1) by transformed keratinocytes is dependent on the activity of p38 mitogen-activated protein kinase. J. Cell Sci. 113, 227-235.
59. Johns, A., Freay, A.D., Fraser, W., Korach, K.S., and Rubanyi, G.M. (1996). Disruption of estrogen receptor gene prevents 17b estradiol-induced angiogenesis in transgenic mice. Endocrinology 137, 4511-4513.
60. Juan, S.H., Lee, J.L., Ho, P.Y., Lee, Y.H., and Lee, W.S. (2006). Antiproliferative and antiangiogenic effects of 3-methylcholanthrene, an aryl-hydrocarbon receptor agonist, in human umbilical vascular endothelial cells. Eur. J. Pharmacol. 530, 1-8.
61. Kazlauskas, A., Sundstrom, S., Poellinger, L., and Pongratz, I. (2001). The hsp90 chaperone complex regulates intracellular localization of the dioxin receptor. Mol. Cell. Biol. 21, 2594-2607.
62. Kim, D.W., Gazourian, L., Quadri, S.A., Romieu-Mourez, R., Sherr, D.H., and Sonenshein, G.E. (2000). The RelA NF-κB subunit and the aryl hydrocarbon receptor (AhR) cooperate to transactivate the c-myc promoter in mammary cells. Oncogene 19, 5498-5506.
63. Kolluri, S.K., Weiss, C., Koff, A., and Gottlicher, M. (1999). p27(Kip1) induction and inhibition of proliferation by the intracellular Ah receptor in developing thymus and hepatoma cells. Genes Dev. 13, 1742-1753.
64. Krishnan, V., Porter, W., Santostefano, M., Wang, X., and Safe, S. (1995). Molecular mechanism of inhibition of estrogen-induced cathepsin D gene expression by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in MCF-7 cells. Mol. Cell. Biol. 15, 6710-6719.
65. Lahvis, G.P., Lindell, S.L., Thomas, R.S., McCuskey, R.S., Murphy, C., Glover, E., Bentz, M., Southard, J., and Bradfield, C.A. (2000). Portosystemic shunting and persistent fetal vascular structures in aryl hydrocarbon receptor-deficient mice. Proc. Natl. Acad. Sci. USA 97, 10442-10447.
66. Lahvis, G.P., Pyzalski, R.W., Glover, E., Pitot, H.C., McElwee, M.K., and Bradfield, C.A. (2005). The aryl hydrocarbon receptor is required for developmental closure of the ductus venosus in the neonatal mouse. Mol. Pharmacol. 67, 714-720.
67. Leppert, D., Lindberg, R.L., Kappos, L., and Leib, S.L. (2001). Matrix metalloproteinases: multifunctional effectors of inflammation in multiple sclerosis and bacterial meningitis. Brain Res. Brain Res. Rev. 36, 249-257.
68. Lin, T.M., Ko, K., Moore, R.W., Simanainen, U., Oberley, T.D., and Peterson, R.E. (2002). Effects of aryl hydrocarbon receptor null mutation and in utero and lactational 2,3,7,8-tetrachlorodibenzo-p-dioxin exposure on prostate and seminal vesicle development in C57BL/6 mice. Toxicol. Sci. 68, 479-487.
69. Mangelsdorf, D.J., Thummel, C., Beato, M., Herrlich, P., Schutz, G., Umesono, K., Blumberg, B., Kastner, P., Mark, M., Chambon, P., and Evans, R.M. (1995). The nuclear receptor super-family: the second decade. Cell 83, 835-839.
70. Marin-Castano, M.E., Elliot, S.J., Potier, M., Karl, M., Striker, L.J., Striker, G.E., Csaky, K.G., and Cousins, S.W. (2003). Regulation of estrogen receptors and MMP-2 expression by estrogens in human retinal pigment epithelium. Invest. Ophthalmol. Vis. Sci. 44, 50-59.
71. Mark, M., Ghyselinck, N.B., Wendling, O., Dupe, V., Mascrez, B., Kastner, P., and Chambon, P. (1999). A genetic dissection of the retinoid signalling pathway in the mouse. Proc. Nutr. Soc. 58, 609-613.
72. Martinez, J.M., Afshari, C.A., Bushel, P.R., Masuda, A., Takahashi, T., and Walker, N.J. (2002). Differential toxicogenomic responses to 2,3,7,8-tetrachlorodibenzo-p-dioxin in malignant and nonmalignant human airway epithelial cells. Toxicol. Sci. 69, 409-423.
73. Mathew, L.K., Andreasen, E.A., and Tanguay, R.L. (2006). Aryl hydrocarbon receptor activation inhibits regenerative growth. Mol. Pharmacol. 69, 257-265.
74. Matikainen, T., Perez, G.I., Jurisicova, A., Pru, J.K., Schlezinger, J.J., Ryu, H.Y., Laine, J., Sakai, T., Korsmeyer, S.J., Casper, R.F., et al. (2001). Aromatic hydrocarbon receptor-driven Bax gene expression is required for premature ovarian failure caused by biohazardous environmental chemicals. Nat. Genet. 28, 355-360.
75. Matsushita, N., Sogawa, K., Ema, M., Yoshida, A., and Fujii-Kuriyama, Y. (1993). A factor binding to the xenobiotic responsive element (XRE) of P-4501A1 gene consists of at least two helix-loop-helix proteins, Ah receptor and Arnt. J. Biol. Chem. 268, 21002-21006.
76. Miettinen, H.M., Huuskonen, H., Partanen, A.M., Miettinen, P., Tuomisto, J.T., Pohjanvirta, R., and Tuomisto, J. (2004). Effects of epidermal growth factor receptor deficiency and 2,3,7,8-tetrachlorodibenzo-p-dioxin on fetal development in mice. Toxicol. Lett. 150, 285-291.
77. Mimura, J. and Fujii-Kuriyama, Y. (2003). Functional role of AhR in the expression of toxic effects by TCDD. Biochim. Biophys. Acta 1619, 263-268.
78. Miyamoto, K. (2004). Effects of dioxin on gene expression in female reproductive system in the rat. Environ. Sci. 11, 47-55.
79. Mizumoto, H., Saito, T., Ashihara, K., Nishimura, M., Tanaka, R., and Kudo, R. (2002). Acceleration of invasive activity via matrix metalloproteinases by transfection of the estrogen receptor-a gene in endometrial carcinoma cells. Int. J. Cancer 100, 401-406.
80. Mizutani, T., Yoshino, M., Satake, T., Nakagawa, M., Ishimura, R., Tohyama, C., Kokame, K., Kangawa, K., and Miyamoto, K. (2004). Identification of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)-inducible and -suppressive genes in the rat placenta: induction of interferon-regulated genes with possible inhibitory roles for angiogenesis in the placenta. Endocr. J. 51, 569-577.
81. Moon, S.K., Cho, G.O., Jung, S.Y., Gal, S.W., Kwon, T.K., Lee, Y.C., Madamanchi, N.R., and Kim, C.H. (2003). Quercetin exerts multiple inhibitory effects on vascular smooth muscle cells: role of ERK1/2, cell-cycle regulation, and matrix metalloproteinase-9. Biochem. Biophys. Res. Commun. 301, 1069-1078.
82. Moon, S.K., Cha, B.Y., and Kim, C.H. (2004a). ERK1/2 mediates TNFα-induced matrix metalloproteinase-9 expression in human vascular smooth muscle cells via the regulation of NF-κB and AP-1: involvement of the ras dependent pathway. J. Cell Physiol. 198, 417-427.
83. Moon, S.K., Kim, H.M., and Kim, C.H. (2004b). PTEN induces G1 cell cycle arrest and inhibits MMP-9 expression via the regulation of NF-κB and AP-1 in vascular smooth muscle cells. Arch. Biochem. Biophys. 421, 267-276.
84. Moser, M., Binder, O., Wu, Y., Aitsebaomo, J., Ren, R., Bode, C., Bauten, V.L., Conlon, F.L., and Patterson, C. (2003). BMPER, a novel endothelial cell precursor-derived protein, antagonizes bone morphogenetic protein signaling and endothelial cell differentiation. Mol. Cell. Biol. 23, 5664-5679.
85. Mott, J.D. and Werb, Z. (2004). Regulation of matrix biology by matrix metalloproteinases. Curr. Opin. Cell Biol. 16, 558-564.
86. Mukerjee, D. (1998). Health impact of polychlorinated dibenzo-p-dioxins: a critical review. J. Air Waste Management Assoc. 48, 157-165.
87. Murphy, K.A., Villano, C.M., Dorn, R., and White, L.A. (2004). Interaction between the aryl hydrocarbon receptor and retinoic acid pathways increases matrix metalloproteinase-1 expression in keratinocytes. J. Biol. Chem. 279, 25284-25293.
88. Ohtake, F., Takeyama, K., Matsumoto, T., Kitagawa, H., Yamamoto, Y., Nohara, K., Tohyama, C., Krust, A., Mimura, J., Chambon, P., et al. (2003). Modulation of oestrogen receptor signalling by association with the activated dioxin receptor. Nature 423, 545-550.
89. Peschon, J.J., Slack, J.L., Reddy, P., Stocking, K.L., Sunnarborg, S.W., Lee, D.C., Russell, W.E., Castner, B.J., Johnson, R.S., Fitzner, J.N., et al. (1998). An essential role for ectodomain shedding in mammalian development. Science 282, 1281-1284.
90. Philip, S., Bulbule, A., and Kundu, G.C. (2004). Matrix metalloproteinase-2: mechanism and regulation of NF-κB-mediated activation and its role in cell motility and ECM-invasion. Glycoconj. J. 21, 429-441.
91. Pilcher, B.K., Gaither-Ganim, J., Parks, W.C., and Welgus, H.G. (1997). Cell type-specific inhibition of keratinocyte collagenase-1 expression by basic fibroblast growth factor and keratinocyte growth factor. A common pathway. J. Biol. Chem. 272, 18147-18154.
92. Potier, M., Elliot, S.J., Tack, I., Lenz, O., Striker, G.E., Striker, L.J., and Karl, M. (2001). Expression and regulation of estrogen receptors in mesangial cells: influence on matrix metalloproteinase-9. J. Am. Soc. Nephrol. 12, 241-251.
93. Puga, A., Nebert, D.W., and Carrier, F. (1992). Dioxin induces expression of c-fos and c-jun proto-oncogenes and a large increase in transcription factor AP-1. DNA Cell Biol. 11, 269-281.
94. Puga, A., Maier, A., and Medvedovic, M. (2000). The transcriptional signature of dioxin in human hepatoma HepG2 cells. Biochem. Pharmacol. 60, 1129-1142.
95. Puga, A., Sartor, M.A., Huang, M.Y., Kerzee, J.K., Wei, Y.D., Tomlinson, C.R., Baxter, C.S., and Medvedovic, M. (2004). Gene expression profiles of mouse aorta and cultured vascular smooth muscle cells differ widely, yet show common responses to dioxin exposure. Cardiovasc. Toxicol. 4, 385-404.
96. Radisky, D.C. and Bissell, M.J. (2006). Matrix metalloproteinase-induced genomic instability. Curr. Opin. Genet. Dev. 16, 45-50.
97. Renaud, J.P. and Moras, D. (2000). Structural studies on nuclear receptors. Cell Mol. Life Sci. 57, 1748-1769.
98. Reyes, H., Reisz-Porszasz, S., and Hankinson, O. (1992). Identification of the Ah receptor nuclear translocator protein (Arnt) as a component of the DNA binding form of the Ah receptor. Science 256, 1193-1195.
99. Rodgers, R.J., Irving-Rodgers, H.F., and van Wezel, I.L. (2000). Extracellular matrix in ovarian follicles. Mol. Cell. Endocrinol. 163, 73-79.
100. Rowlands, J.C., McEwan, I.J., and Gustafsson, J.A. (1996). Trans-activation by the human aryl hydrocarbon receptor and aryl hydrocarbon receptor nuclear translocator proteins: direct interactions with basal transcription factors. Mol. Pharmacol. 50, 538-548.
101. Rundhaug, J.E. (2005). Matrix metalloproteinases and angiogenesis. J. Cell Mol. Med. 9, 267-285.
102. Safe, S., Wormke, M., and Samudio, I. (2000). Mechanisms of inhibitory aryl hydrocarbon receptor-estrogen receptor cross-talk in human breast cancer cells. J. Mammary Gland Biol. Neoplasia 5, 295-306.
103. Schmidt, J.V., Su, G.H., Reddy, J.K., Simon, M.C., and Bradfield, C.A. (1996). Characterization of a murine Ahr null allele: involvement of the Ah receptor in hepatic growth and development. Proc. Natl. Acad. Sci. USA 93, 6731-6736.
104. Schule, R., Rangarajan, P., Yang, N., Kliewer, S., Ransone, L.J., Bolado, J., Verma, I.M., and Evans, R.M. (1991). Retinoic acid is a negative regulator of AP-1-responsive genes. Proc. Natl. Acad. Sci. USA 88, 6092-6096.
105. Sheu, B.C., Hsu, S.M., Ho, H.N., Lien, H.C., Huang, S.C., and Lin, R.H. (2001). A novel role of metalloproteinase in cancer-mediated immunosuppression. Cancer Res. 61, 237-242.
106. Sogawa, K., Iwabuchi, K., Abe, H., and Fujii-Kuriyama, Y. (1995). Transcriptional activation domains of the Ah receptor and Ah receptor nuclear translocator. J. Cancer Res. Clin. Oncol. 121, 612-620.
107. Sutler, T.R., Guzman, K., Dold, K.M., and Greenlee, W.F. (1991). Targets for dioxin: genes for plasminogen activator inhibitor-2 and interleukin-1b. Science 254, 415-418.
108. Swanson, H.I. and Yang, J.H. (1998). The aryl hydrocarbon receptor interacts with transcription factor IIB. Mol. Pharmacol. 54, 671-677.
109. Takagi, T.N., Matsui, K.A., Yamashita, K., Ohmori, H., and Yasuda, M. (2000). Pathogenesis of cleft palate in mouse embryos exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). Teratog. Carcinog. Mutagen 20, 73-86.
110. Tayebjee, M.H., Lip, G.Y., and MacFadyen, R.J. (2005). What role do extracellular matrix changes contribute to the cardiovascular disease burden of diabetes mellitus? Diabet. Med. 22, 1628-1635.
111. Thackaberry, E.A., Jiang, Z., Johnson, C.D., Ramos, K.S., and Walker, M.K. (2005). Toxicogenomic profile of 2,3,7,8-tetrachlorodibenzo-p-dioxin in the murine fetal heart: modulation of cell cycle and extracellular matrix genes. Toxicol. Sci. 88, 231-241.
112. Tian, Y., Ke, S., Denison, M.S., Rabson, A.B., and Gallo, M.A. (1999). Ah receptor and NF-κB interactions, a potential mechanism for dioxin toxicity. J. Biol. Chem. 274, 510-515.
113. Tian, Y., Rabson, A.B., and Gallo, M.A. (2002). Ah receptor and NF-κB interactions: mechanisms and physiological implications. Chem. Biol. Interact. 141, 97-115.
114. Tijet, N., Boutros, P.C., Moffat, I.D., Okey, A.B., Tuomisto, J., and Pohjanvirta, R. (2006). Aryl hydrocarbon receptor regulates distinct dioxin-dependent and dioxin-independent gene batteries. Mol. Pharmacol. 69, 140-153.
115. Tower, G.B., Coon, C.I., Belguise, K., Chalbos, D., and Brinckerhoff, C.E. (2003). Fra-1 targets the AP-1 site/2G single nucleotide polymorphism (ETS site) in the MMP-1 promoter. Eur. J. Biochem. 270, 4216-4225.
116. Vezina, C.M., Walker, N.J., and Olson, J.R. (2004). Subchronic exposure to TCDD, PeCDF, PCB126, and PCB153: effect on hepatic gene expression. Environ. Health Perspect. 112, 1636-1644.
117. Vihinen, P. and Kahari, V.M. (2002). Matrix metalloproteinases in cancer: prognostic markers and therapeutic targets. Int. J. Cancer 99, 157-166.
118. Villano, C.M., Murphy, K.A., Akintobi, A., and White, L.A. (2006). 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) induces matrix metalloproteinase (MMP) expression and invasion in A2058 melanoma cells. Toxicol. Appl. Pharmacol. 210, 212-224.
119. Vincenti, M.P., White, L.A., Schroen, D.J., Benbow, U., and Brinckerhoff, C.E. (1996). Regulating expression of the gene for matrix metalloproteinase-1 (MMP-1): mechanisms that control enzyme activity, transcription and mRNA stability. Crit. Rev. Eukar. Gene Expr. 6, 391-411.
120. Vincenti, M.P., Coon, C.I., and Brinckerhoff, C.E. (1998). Nuclear factor κB/p50 activates an element in the distal matrix metalloproteinase 1 Promoter in interleukin-1β-stimulated synovial fibroblasts. Arthritis Rheum. 41, 1987-1994.
121. Visse, R. and Nagase, H. (2003). Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry. Circ. Res. 92, 827-839.
122. Vorderstrasse, B.A., Fenton, S.E., Bohn, A.A., Cundiff, J.A., and Lawrence, B.P. (2004). A novel effect of dioxin: exposure during pregnancy severely impairs mammary gland differentiation. Toxicol. Sci. 78, 248-257.
123. Wang, Y.A., Shen, K., Wang, Y., and Brooks, S.C. (2005). Retinoic acid signaling is required for proper morphogenesis of mammary gland. Dev. Dyn. 234, 892-899.
124. Watson, A.J. and Hankinson, O. (1992). Dioxin- and Ah receptor-dependent protein binding to xenobiotic responsive elements and G-rich DNA studied by in vivo footprinting. J. Biol. Chem. 267, 6874-6878.
125. Watt, K., Jess, T.J., Kelly, S.M., Price, N.C., and McEwan, I.J. (2005). Induced alpha-helix structure in the aryl hydrocarbon receptor transactivation domain modulates protein-protein interactions. Biochemistry 44, 734-743.
126. White, L.A. and Brinckerhoff, C.E. (1995). Two activator protein-1 elements in the matrix metalloproteinase-1 promoter have differential effects on transcription and bind JunD, c-Fos and Fra-2. Matrix Biol. 14, 715-725.
127. Wiseman, B.S., Sternlicht, M.D., Lund, L.R., Alexander, C.M., Mott, J., Bissell, M.J., Soloway, P., Itohara, S., and Werb, Z. (2003). Site-specific inductive and inhibitory activities of MMP-2 and MMP-3 orchestrate mammary gland branching morphogenesis. J. Cell Biol. 162, 1123-1133.
128. Witty, J.P., Wright, J.H., and Matrisian, L.M. (1995). Matrix metalloproteinases are expressed during ductal and alveolar mammary morphogenesis, and misregulation of stromelysin-1 in transgenic mice induces unscheduled alveolar development. Mol. Biol. Cell 6, 1287-1303.
129. Woessner Jr J.F. and Nagase, H. (2000). The Matrix Metalloproteinases and TIMPs (Oxford, UK: Oxford University Press).
130. Wormke, M., Stoner, M., Saville, B., and Safe, S. (2000). Cross-talk between estrogen receptor a and the aryl hydrocarbon receptor in breast cancer cells involves unidirectional activation of proteasomes. FEBS Lett. 478, 109-112.
131. Xu, J., Rodriguez, D., Petitclerc, E., Kim, J.J., Hangai, M., Moon, Y.S., Davis, G.E., Brooks, P.C., and Yuen, S.M. (2001). Proteolytic exposure of a cryptic site within collagen type IV is required for angiogenesis and tumor growth in vivo. J. Cell Biol. 154, 1069-1079.
132. Yan, Y.L., Willoughby, J., Liu, D., Crump, J.G., Wilson, C., Miller, C.T., Singer, A., Kimmel, C., Westerfield, M., and Postlethwait, J.H. (2005). A pair of Sox: distinct and overlapping functions of zebrafish sox9 co-orthologs in craniofacial and pectoral fin development. Development 132, 1069-1083.
133. Yin, H., Li, Y., and Sutter, T.R. (1994). Dioxin-enhanced expression of interleukin-1β in human epidermal keratinocytes: potential role in the modulation of immune and inflammatory responses. Exp. Clin. Immunogenet. 11, 128-135.
134. Young, D.A., Lakey, R.L., Pennington, C.J., Jones, D., Kevorkian, L., Edwards, D.R., Cawston, T.E., and Clark, I.M. (2005). Histone deacetylase inhibitors modulate metalloproteinase gene expression in chondrocytes and block cartilage resorption. Arthritis Res. Ther. 7, R503-512.
135. Yu, Q., and Stamenkovic, I. (2000). Cell surface-localized matrix metalloproteinase-9 proteolytically activates TGF-β and promotes tumor invasion and angiogenesis. Genes Dev. 14, 163-176.
136. Yuan, W. and Varga, J. (2001). Transforming growth factor-beta repression of matrix metalloproteinase-1 in dermal fibroblasts involves Smad3. J. Biol. Chem. 276, 38502-38510.
137. Zodrow, J.M. and Tanguay, R.L. (2003). 2,3,7,8-tetrachlorodibenzo-p- dioxin inhibits zebrafish caudal fin regeneration. Toxicol. Sci. 76, 151-161.